| Trial ID: | L0874 |
| Source ID: | IRCT201312132480N5
|
| Associated Drug: |
Genistein
|
| Title: |
The effect of genistein supplementation on inflammatory and oxidative indices and lipid profile in non-alcoholic fatty liver patients
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non alcoholic fatty liver. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Intervention group: 250 mg genistein as capsule once per day for 8 weeksmanufacture company: BOC SCI. Intervention 2: Control group: wheat starch in capsule once a day for 8 weeks.;Treatment - Drugs;Placebo;Intervention group: 250 mg genis
|
| Outcome Measures: |
Malondialdehyde. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;Liver steatosis. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By fibroscan device.;TNF- alpha. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;IL-6. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;ALT. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;AST. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;HDL. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;LDL. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;Total cholesetrol. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.;Triglyceride. Timepoint: Before intervention and two months after intervention inception. Method of measurement: By serum analysis.Waist circumference. Timepoint: Before and two months after intervention inception. Method of measurement: By tapeline in cm.;Waist circumference. Timepoint: Before and two months after intervention inception. Method of measurement: By scale in KG.
|
| Sponsor/Collaborators: |
Shiraz University Of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years70 years
|
| Phases: |
Phase 3
|
| Enrollment: |
100
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Randomization carry out by simple randomization.
|
| Start Date: |
11/07/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/2209
|
